BIOMAT Database Logo BIOMAT Database Logo

Streptococcus intermedius-associated late-onset endophthalmitis after trabeculectomy with adjunctive mitomycin C. 2009

Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Department of Ophthalmology, Gifu University Graduate School of Medicine, Gifu, Japan.

OBJECTIVE To report a woman with congenital rubella syndrome of delayed-onset, bleb-related endophthalmitis induced by Streptococcus intermedius. METHODS Interventional case report. RESULTS A 33-year-old woman who underwent bilateral trabeculectomy with adjunctive mitomycin C, 11 years earlier presented with redness and blurred vision in her right eye. She had received a topical antimicrobial agent because of bleb leak before presentation. She underwent anterior chamber tap and complete vitrectomy with intravitreal antibiotics. Cultures from the vitreous aspirate grew gram-positive cocci. The DNA from the microorganism was sequenced and identified as S. intermedius. Three months after the surgical intervention, her right eye showed no residual inflammation with a best-corrected visual acuity of 30/200. CONCLUSIONS Bleb-associated endophthalmitis caused by S. intermedius is responsive to intravitreal antibiotics and vitrectomy, and special care should be taken to identify a bacterial pathogen.

UI MeSH Term Description Entries
D009877 Endophthalmitis Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection. Ophthalmia,Infectious Endophthalmitis,Endophthalmitides,Endophthalmitides, Infectious,Endophthalmitis, Infectious,Infectious Endophthalmitides,Ophthalmias
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013290 Streptococcal Infections Infections with bacteria of the genus STREPTOCOCCUS. Group A Strep Infection,Group A Streptococcal Infection,Group A Streptococcal Infections,Group B Strep Infection,Group B Streptococcal Infection,Group B Streptococcal Infections,Infections, Streptococcal,Infection, Streptococcal,Streptococcal Infection

Related Publications

Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Gemella species-associated late-onset endophthalmitis after trabeculectomy with adjunctive mitomycin C.
August 2009, Journal of glaucoma,
Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Late bleb-related endophthalmitis after trabeculectomy with mitomycin C.
February 1999, Ophthalmic surgery and lasers,
Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Bleb-related endophthalmitis after trabeculectomy with mitomycin C.
April 1996, Ophthalmology,
Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Delayed-onset pneumococcal endophthalmitis after mitomycin-C trabeculectomy: association with cryptic nasolacrimal obstruction.
February 1995, Journal of glaucoma,
Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Nd:YAG laser goniopuncture for late bleb failure after trabeculectomy with adjunctive mitomycin C.
March 2014, JAMA ophthalmology,
Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil.
July 1991, Ophthalmology,
Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Retained cellulose sponge after trabeculectomy with adjunctive subconjunctival mitomycin C.
July 1994, American journal of ophthalmology,
Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment.
October 1997, The British journal of ophthalmology,
Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C.
July 2004, Optometry and vision science : official publication of the American Academy of Optometry,
Kiyofumi Mochizuki, and Masako Kumada, and Shinsuke Suemori, and Hideaki Kawakami, and Akira Sawada, and Tetsuya Yamamoto, and Hiroshige Mikamo
Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
November 2016, Acta ophthalmologica,
Copied contents to your clipboard!